Furthermore, we analyzed the relationship between SESN1 and the survival probability of patients with NB using the R2, NBL, E‐MTAB‐8284, and GSE40710 datasets and found that patients with high expression of SENS1 had better Event‐free and overall survival probability than patients with low expression of SESN1 (Figure S1C,D). This evidence concerns the gene SESN1 and neuroblastoma.